Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1522077

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1522077

Europe Precision Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Type, By Application, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 148 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Precision Diagnostics Market would witness market growth of 17.6% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Precision Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,500.1 million by 2031. The UK market is exhibiting a CAGR of 16.6% during (2024 - 2031). Additionally, The France market would experience a CAGR of 18.9% during (2024 - 2031).

Precision diagnostics encompass a wide range of applications across various fields of medicine, leveraging advanced technologies to enhance diagnostic accuracy, personalize treatment strategies, and improve patient outcomes.

Moreover, precision diagnostics play a crucial role in oncology, where personalized treatment approaches are increasingly based on tumors' genetic and molecular characteristics. Identifying mutations (e.g., BRCA1/2 in breast cancer) influencing cancer risk and treatment response.

Europe faces a high burden of respiratory diseases such as chronic obstructive pulmonary disease and respiratory infections due to factors like air pollution, an aging population, and lifestyle habits. As per Eurostat, in 2020, there were 3,47,867 deaths in the EU resulting from diseases of the respiratory system, equivalent to 6.7 % of all deaths among residents. In 2020, the proportion of deaths from respiratory diseases in Malta, Denmark, and Ireland was considerably higher than the EU average, at 10.5 %, 10.4 %, and 10.0 %, respectively.

Based on End-use, the market is segmented into Clinical Laboratories, Hospitals, and Others. Based on Type, the market is segmented into Genetic Tests, Esoteric Tests, Direct to Consumer Tests, and Others. Based on Application, the market is segmented into Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG (Siemens AG)
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Qiagen N.V
  • Hologic, Inc.

Europe Precision Diagnostics Market Report Segmentation

By End-use

  • Clinical Laboratories
  • Hospitals
  • Others

By Type

  • Genetic Tests
  • Esoteric Tests
  • Direct to Consumer Tests
  • Others

By Application

  • Oncology
  • Respiratory Diseases
  • CNS Disorders
  • Immunology
  • Skin Diseases
  • Genetic Diseases
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Precision Diagnostics Market, by End-use
    • 1.4.2 Europe Precision Diagnostics Market, by Type
    • 1.4.3 Europe Precision Diagnostics Market, by Application
    • 1.4.4 Europe Precision Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
    • 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jul - 2024, May) Leading Players
  • 4.4 Porter Five Forces Analysis

Chapter 5. Europe Precision Diagnostics Market by End-use

  • 5.1 Europe Clinical Laboratories Market by Country
  • 5.2 Europe Hospitals Market by Country
  • 5.3 Europe Others Market by Country

Chapter 6. Europe Precision Diagnostics Market by Type

  • 6.1 Europe Genetic Tests Market by Country
  • 6.2 Europe Esoteric Tests Market by Country
  • 6.3 Europe Direct to Consumer Tests Market by Country
  • 6.4 Europe Others Market by Country

Chapter 7. Europe Precision Diagnostics Market by Application

  • 7.1 Europe Oncology Market by Country
  • 7.2 Europe Respiratory Diseases Market by Country
  • 7.3 Europe CNS Disorders Market by Country
  • 7.4 Europe Immunology Market by Country
  • 7.5 Europe Skin Diseases Market by Country
  • 7.6 Europe Genetic Diseases Market by Country
  • 7.7 Europe Others Market by Country

Chapter 8. Europe Precision Diagnostics Market by Country

  • 8.1 Germany Precision Diagnostics Market
    • 8.1.1 Germany Precision Diagnostics Market by End-use
    • 8.1.2 Germany Precision Diagnostics Market by Type
    • 8.1.3 Germany Precision Diagnostics Market by Application
  • 8.2 UK Precision Diagnostics Market
    • 8.2.1 UK Precision Diagnostics Market by End-use
    • 8.2.2 UK Precision Diagnostics Market by Type
    • 8.2.3 UK Precision Diagnostics Market by Application
  • 8.3 France Precision Diagnostics Market
    • 8.3.1 France Precision Diagnostics Market by End-use
    • 8.3.2 France Precision Diagnostics Market by Type
    • 8.3.3 France Precision Diagnostics Market by Application
  • 8.4 Russia Precision Diagnostics Market
    • 8.4.1 Russia Precision Diagnostics Market by End-use
    • 8.4.2 Russia Precision Diagnostics Market by Type
    • 8.4.3 Russia Precision Diagnostics Market by Application
  • 8.5 Spain Precision Diagnostics Market
    • 8.5.1 Spain Precision Diagnostics Market by End-use
    • 8.5.2 Spain Precision Diagnostics Market by Type
    • 8.5.3 Spain Precision Diagnostics Market by Application
  • 8.6 Italy Precision Diagnostics Market
    • 8.6.1 Italy Precision Diagnostics Market by End-use
    • 8.6.2 Italy Precision Diagnostics Market by Type
    • 8.6.3 Italy Precision Diagnostics Market by Application
  • 8.7 Rest of Europe Precision Diagnostics Market
    • 8.7.1 Rest of Europe Precision Diagnostics Market by End-use
    • 8.7.2 Rest of Europe Precision Diagnostics Market by Type
    • 8.7.3 Rest of Europe Precision Diagnostics Market by Application

Chapter 9. Company Profiles

  • 9.1 Abbott Laboratories
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Acquisition and Mergers:
    • 9.1.6 SWOT Analysis
  • 9.2 F. Hoffmann-La Roche Ltd.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
    • 9.2.6 SWOT Analysis
  • 9.3 Siemens Healthineers AG (Siemens AG)
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
      • 9.3.5.2 Product Launches and Product Expansions:
      • 9.3.5.3 Acquisition and Mergers:
    • 9.3.6 SWOT Analysis
  • 9.4 Thermo Fisher Scientific, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expenses
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
    • 9.4.6 SWOT Analysis
  • 9.5 Danaher Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
    • 9.5.6 SWOT Analysis
  • 9.6 Agilent Technologies, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
      • 9.6.5.2 Product Launches and Product Expansions:
    • 9.6.6 SWOT Analysis
  • 9.7 BioMerieux S.A.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Partnerships, Collaborations, and Agreements:
      • 9.7.5.2 Acquisition and Mergers:
    • 9.7.6 SWOT Analysis
  • 9.8 Becton, Dickinson, and Company
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 SWOT Analysis
  • 9.9 Qiagen N.V.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expenses
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Partnerships, Collaborations, and Agreements:
      • 9.9.5.2 Product Launches and Product Expansions:
    • 9.9.6 SWOT Analysis
  • 9.10. Hologic, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Europe Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 2 Europe Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Precision Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions - Precision Diagnostics Market
  • TABLE 5 Acquisition and Mergers - Precision Diagnostics Market
  • TABLE 6 Europe Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 7 Europe Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 8 Europe Clinical Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 9 Europe Clinical Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 10 Europe Hospitals Market by Country, 2020 - 2023, USD Million
  • TABLE 11 Europe Hospitals Market by Country, 2024 - 2031, USD Million
  • TABLE 12 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 13 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 14 Europe Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 15 Europe Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 16 Europe Genetic Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 17 Europe Genetic Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 18 Europe Esoteric Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 19 Europe Esoteric Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 20 Europe Direct to Consumer Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 21 Europe Direct to Consumer Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 22 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 23 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 24 Europe Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 25 Europe Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 26 Europe Oncology Market by Country, 2020 - 2023, USD Million
  • TABLE 27 Europe Oncology Market by Country, 2024 - 2031, USD Million
  • TABLE 28 Europe Respiratory Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 29 Europe Respiratory Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 30 Europe CNS Disorders Market by Country, 2020 - 2023, USD Million
  • TABLE 31 Europe CNS Disorders Market by Country, 2024 - 2031, USD Million
  • TABLE 32 Europe Immunology Market by Country, 2020 - 2023, USD Million
  • TABLE 33 Europe Immunology Market by Country, 2024 - 2031, USD Million
  • TABLE 34 Europe Skin Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 35 Europe Skin Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 36 Europe Genetic Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 37 Europe Genetic Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 38 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 39 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 40 Europe Precision Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 41 Europe Precision Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 42 Germany Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 43 Germany Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 44 Germany Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 45 Germany Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 46 Germany Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 47 Germany Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 48 Germany Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 49 Germany Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 50 UK Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 51 UK Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 52 UK Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 53 UK Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 54 UK Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 55 UK Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 56 UK Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 57 UK Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 58 France Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 59 France Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 60 France Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 61 France Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 62 France Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 63 France Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 64 France Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 65 France Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 66 Russia Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 67 Russia Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 68 Russia Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 69 Russia Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 70 Russia Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 71 Russia Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 72 Russia Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 73 Russia Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 74 Spain Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 75 Spain Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 76 Spain Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 77 Spain Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 78 Spain Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 79 Spain Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 80 Spain Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 81 Spain Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 82 Italy Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 83 Italy Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 84 Italy Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 85 Italy Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 86 Italy Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 87 Italy Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 88 Italy Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 89 Italy Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 90 Rest of Europe Precision Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 91 Rest of Europe Precision Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 92 Rest of Europe Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
  • TABLE 93 Rest of Europe Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
  • TABLE 94 Rest of Europe Precision Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 95 Rest of Europe Precision Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 96 Rest of Europe Precision Diagnostics Market by Application, 2020 - 2023, USD Million
  • TABLE 97 Rest of Europe Precision Diagnostics Market by Application, 2024 - 2031, USD Million
  • TABLE 98 Key Information - Abbott Laboratories
  • TABLE 99 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 100 Key Information - Siemens Healthineers AG
  • TABLE 101 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 102 Key Information - Danaher Corporation
  • TABLE 103 key Information - Agilent Technologies, Inc.
  • TABLE 104 Key information - BioMerieux S.A.
  • TABLE 105 Key Information - Becton, Dickinson and Company
  • TABLE 106 Key Information - Qiagen N.V.
  • TABLE 107 Key Information - Hologic, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!